Companies: 10,795·Total market cap: $144.5T
Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc.

OCULNASDAQHealthcare● Active
$8.16
$-0.09(-1.09%)
Market Cap$1.8B
P/E Ratio
52W High$16.44
52W Low$6.23

Ocular Therapeutix, Inc. (OCUL) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · OCUL · as of Feb 5, 2026

Latest filing snapshot

325
+51+18.61%vs prior year

Ocular Therapeutix, Inc. (OCUL) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
325
Change (1Y)
+51
Growth % (1Y)
+18.61%
Revenue / Employee
$159.5K
Net Income / Employee
$-818.3K
Market Cap
$1.8B

OCUL Employee Count

2014 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-02-05325+51+18.61%
2025-03-03274+7+2.62%
2024-03-11267-7-2.55%
2023-03-06274+46+20.18%
2022-02-28228+47+25.97%
2021-03-11181+20+12.42%
2020-03-12161-6-3.59%
2019-03-07167+48+40.34%
2018-03-08119+1+0.85%
2017-03-10118+24+25.53%

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Galapagos N.V.
GLPG
Galapagos N.V.
704
#2
ImmunityBio, Inc.
IBRX
ImmunityBio, Inc.
671
#3
Ocular Therapeutix, Inc.
OCUL
Ocular Therapeutix, Inc.YOU
325
#4
Cogent Biosciences, Inc.
COGT
Cogent Biosciences, Inc.
205
#5
Liquidia Corporation
LQDA
Liquidia Corporation
170
#6
Structure Therapeutics Inc.
GPCR
Structure Therapeutics Inc.
163
#7
Edgewise Therapeutics, Inc.
EWTX
Edgewise Therapeutics, Inc.
117
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · OCUL peer comparison

About OCUL employees

OCUL Employees · Headcount

Ocular Therapeutix, Inc. (OCUL) employee data is sourced from the annual SEC 10-K filing. As of 2025, Ocular Therapeutix, Inc. had 325 full-time employees globally. Full-time employees only. Global consolidated headcount.

Ocular Therapeutix, Inc. employs 325 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $159,455, reflecting the company's operational efficiency.

Ocular Therapeutix, Inc.'s workforce increased by 51 (18.61%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Ocular Therapeutix, Inc.'s revenue per employee of $159,455 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

OCUL Employees · 5 questions

As of the latest SEC 10-K filing (2025), Ocular Therapeutix, Inc. had 325 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Ocular Therapeutix, Inc. employee counthow many employees does Ocular Therapeutix, Inc. haveOCUL total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-05